Results 81 to 90 of about 58,426 (305)
Medicina v Kuzbasse, 2022 There are many theories of the genesis of cholelithiasis in the literature, but none of the theories is perfect. Currently, there are no works on the development of experimental prevention of cholesterol cholelithiasis, based on the etiology of ...
Леонид Николаевич Иванов +2 more
doaj
Бюллетень сибирской медицины, 2009 To study influence of therapy Biltritsid and Ursosan on existence of cholelithiasis at opisthorchosis. Are inspected 87 patients with the cholelithiasis and chronic opisthorchosis.
A. L. Korkin
doaj +1 more source
Early and late complications of bariatric operation. [PDF]
, 2018 Weight loss surgery is one of the fastest growing segments of the surgical discipline. As with all medical procedures, postoperative complications will occur. Acute care surgeons need to be familiar with the common problems and their management. Although
Beekley, Alec +3 more
core +1 more source
Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation [PDF]
, 2012 ObjectivesTo investigate whether Helicobacter spp. infection and the cagA of H. pylori are associated with hepatobiliary pathology, specifically biliary inflammation, cell proliferation and cholangiocarcinoma (CCA).MethodsHelicobacter species including H.
Bhudhisawasdi, Vajarabhongsa +6 more
core +1 more source
Biliary Microbiota and Bile Acid Composition in Cholelithiasis
BioMed Research International, 2020 Background A functional interplay between BAs and microbial composition in gut is a well-documented phenomenon. In bile, this phenomenon is far less studied, and with this report, we describe the interactions between the BAs and microbiota in this ...
V. Petrov +7 more
semanticscholar +1 more source
Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment
Haemophilia, EarlyView.ABSTRACT Introduction Recent advancements in haemophilia treatment have introduced a range of innovative therapies, including activated FVIII mimetics, ultra‐extended half‐life recombinant FVIII, rebalancing agents and gene therapy. These developments have transformed treatment options and expanded prophylaxis strategies.
Yesim Dargaud +5 more
wiley +1 more source
Cystic fibrosis gene mutations and gastrointestinal diseases [PDF]
, 2010 Background: This study examined if CF mutation heterozygosity is associated with diseases of gastrointestinal epithelial barrier function. Design and methods: Swedish registers identified 865 patients with a diagnosis of CF between 1968 and 2003 and ...
Askling, J. +4 more
core +1 more source
Hyperuricaemia in type 1 Gaucher disease: is uric acid a biomarker for disease severity?
Internal Medicine Journal, EarlyView.Abstract Background Elevated serum uric acid (SUA) levels were observed in Gaucher disease type 1 (GD1) patients followed for two decades in northern Israel. There are no previous reports regarding hyperuricaemia in GD1 patients. Aims We aimed to evaluate the frequency of hyperuricaemia in GD1 patients and its correlation to disease severity ...
Zufit Hexner‐Erlichman +4 more
wiley +1 more source
Bile bacteria of patients with cholelithiasis and theirs antibiogram [PDF]
, 2013 To prevent post cholecystectomy infection, the most common microorganisms causing it and their antibacterial susceptibility pattern should be determined.
Imani, Reza. +1 more
core +1 more source